MétaCan
Menu
Back to cohort
Record W3028415293 · doi:10.1200/po.19.00298

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition

2020· article· en· W3028415293 on OpenAlexaff
Liana Nobre, Michal Zápotocký, Vijay Ramaswamy, Scott Ryall, Julie Bennett, Daniel Alderete, Julia Balaguer Guill, Lorena Baroni, Ute Bartels, Abhishek Bavle, Miriam Bornhorst, Daniel R. Boué, Adela Cañete, Murali Chintagumpala, Scott Coven, Ofelia Cruz, Sonika Dahiya, Peter B. Dirks, Ira J. Dunkel, David D. Eisenstat, Cécile Faure‐Conter, Elizabeth Finch, Jonathan L. Finlay, Didier Frappaz, Maria Luisa Garrè, Karen Gauvain, Anne Grete Bechensteen, Jordan R. Hansford, Inga Harting, Péter Hauser, Lili‐Naz Hazrati, Annie Huang, Sarah G. Injac, Valentina Iurilli, Matthias A. Karajannis, Gurcharanjeet Kaur, Martin Kynčl, Lenka Krsková, Normand Laperrière, Valérie Larouche, Álvaro Lassaletta, Sarah Leary, Frank Y. Lin, Samantha Mascelli, Tara McKeown, Till Milde, Andrés Morales La Madrid, Giovanni Morana, Helena Mörse, Naureen Mushtaq, Diana S. Osorio, Roger J. Packer, Zdeněk Pavelka, Eduardo Quiroga-Cantero, James T. Rutka, Magnus Sabel, Duarte Salgado, Palma Solano‐Páez, Jaroslav Štěrba, Jack Su, David Sumerauer, Michael D. Taylor, Helen Toledano, Derek S. Tsang, Mariana Valente Fernandes, Frank K.H. van Landeghem, Cornelis M. van Tilburg, Bev Wilson, Olaf Witt, Josef Zámečnı́k, Éric Bouffet, Cynthia Hawkins, Uri Tabori

Bibliographic record

VenueJCO Precision Oncology · 2020
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsUniversité LavalUniversity of AlbertaSickKids FoundationUniversity of TorontoStollery Children's HospitalHospital for Sick Children
FundersNational Cancer Institute
KeywordsMedicineCDKN2AGliomaInternal medicineOncologyDiscontinuationConcomitantV600EChemotherapyCancer researchMutationCancerGene

Abstract

fetched live from OpenAlex

PURPOSE Children with pediatric gliomas harboring a BRAF V600E mutation have poor outcomes with current chemoradiotherapy strategies. Our aim was to study the role of targeted BRAF inhibition in these tumors. PATIENTS AND METHODS We collected clinical, imaging, molecular, and outcome information from patients with BRAF V600E–mutated glioma treated with BRAF inhibition across 29 centers from multiple countries. RESULTS Sixty-seven patients were treated with BRAF inhibition (pediatric low-grade gliomas [PLGGs], n = 56; pediatric high-grade gliomas [PHGGs], n = 11) for up to 5.6 years. Objective responses were observed in 80% of PLGGs, compared with 28% observed with conventional chemotherapy ( P < .001). These responses were rapid (median, 4 months) and sustained in 86% of tumors up to 5 years while receiving therapy. After discontinuation of BRAF inhibition, 76.5% (13 of 17) of patients with PLGG experienced rapid progression (median, 2.3 months). However, upon rechallenge with BRAF inhibition, 90% achieved an objective response. Poor prognostic factors in conventional therapies, such as concomitant homozygous deletion of CDKN2A, were not associated with lack of response to BRAF inhibition. In contrast, only 36% of those with PHGG responded to BRAF inhibition, with all but one tumor progressing within 18 months. In PLGG, responses translated to 3-year progression-free survival of 49.6% (95% CI, 35.3% to 69.5%) versus 29.8% (95% CI, 20% to 44.4%) for BRAF inhibition versus chemotherapy, respectively ( P = .02). CONCLUSION Use of BRAF inhibition results in robust and durable responses in BRAF V600E–mutated PLGG. Prospective studies are required to determine long-term survival and functional outcomes with BRAF inhibitor therapy in childhood gliomas.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.056
Threshold uncertainty score0.615

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.299
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations142
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJCO Precision OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207